MODUS THERAPEUTICS
Modus Therapeutics is a Swedish drug development company developing sevuparin – a novel drug to treat people suffering from Sickle Cell Disease – a painful, inherited blood disorder affecting millions of people around the globe.
MODUS THERAPEUTICS
Industry:
Biotechnology Clinical Trials Pharmaceutical Therapeutics
Founded:
2011-01-01
Address:
Stockholm, Stockholms Lan, Sweden
Country:
Sweden
Website Url:
http://www.modustx.com
Total Employee:
1+
Status:
Active
Contact:
556669-2199
Email Addresses:
[email protected]
Total Funding:
183.5 M SEK
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Nginx Microsoft Exchange Online Office 365 Mail Google Maps
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Hookipa Pharma
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Karolinska
Karolinska investment in Post-IPO Debt - Modus Therapeutics
HealthCap
HealthCap investment in Series A - Modus Therapeutics
Rosetta Capital
Rosetta Capital investment in Venture Round - Modus Therapeutics
Praktikerinvest
Praktikerinvest investment in Venture Round - Modus Therapeutics
KDev Investments
KDev Investments investment in Venture Round - Modus Therapeutics
Ostersjöstiftelsen
Ostersjöstiftelsen investment in Venture Round - Modus Therapeutics
Official Site Inspections
http://www.modustx.com Semrush global rank: 8.3 M Semrush visits lastest month: 335
- Host name: 77.68.2.47
- IP address: 77.68.2.47
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "Modus Therapeutics"
Modus Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 556669-2199 Modus Therapeutics is a Swedish drug development company developing sevuparin – a novel drug to treat people …See details»
About us - Modus Therapeutics
Born: 1965 Education and experience: MD, PhD, Assoc Prof in Cardiology at Karolinska Institute. Viktor Drvota has over 18 years’ experience from venture capital in life sciences. Drvota was responsible for life science at SEB Venture …See details»
Invitation to subscribe for units in Modus Therapeutics Holding AB
Format via the Company's website, www.modustx.com, or be obtained by the Company in paper format at Modus' office with address: Olof Palmes gata 29 IV, 111 22 Stockholm, Sweden. The …See details»
Modus Therapeutics Holding AB - LinkedIn
Modus Therapeutics is a Swedish biotech company developing sevuparin for diseases with high unmet medical need. The Company’s near-term focus is to develop sevuparin for patients with …See details»
Modus Therapeutics
Dec 5, 2024 The company was founded in 2013 by a small group of scientists and doctors in Stockholm, Sweden. The mission of Modus Therapeutics is to develop innovative treatments …See details»
MODTX Company Description - Stock Analysis
Dec 10, 2024 Modus Therapeutics Holding AB (publ), a biotechnology company, develops a treatment for sepsis and septic shock in Sweden. It develops Sevuparin, a lipopolysaccharide …See details»
Annual Report 2021 - modustx.com
Contract manufacturing organization, has started manufacturing sevuparin drug product securing the supply for the Phase II clinical development. This follows a drug supply agreement …See details»
Annual General Meeting in Modus Therapeutics Holding AB (publ) …
Email: [email protected] . Certified Adviser . Svensk Kapitalmarknadsgranskning AB . Phone: +46 11 32 30 732 . Email: [email protected] *** About Modus Therapeutics and sevuparin . …See details»
Modus Therapeutics Holding AB, MODTX:STO profile - FT.com
Modus Therapeutics Holding AB (MODTX:STO) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.See details»
Modus Therapeutics - VentureRadar
Similar Companies: Imara USA Privately Held Imara Inc. is a clinical-stage biotechnology company dedicated to developing and commercializing novel therapeutics to treat patients …See details»
INTERIM REPORT - modustx.com
“Subsidiary” or “Modus Therapeutics” refers to the subsidiary Modus Therapeutics AB with organization number 556669–2199. The third quarter in figures • The loss after tax amounted …See details»
Modus Therapeutics Holding AB (publ) publishes annual report for …
Apr 11, 2024 More information is available at www.modustx.com. Sevuparin is a clinical stage, innovative proprietary polysaccharide drug with a multimodal mechanism of action, including …See details»
Modus Therapeutics - Symbiosis Pharmaceutical Services Starts …
Oct 18, 2021 Modus Therapeutics Holding AB (“Modus”), a company developing innovative treatments for patients with high unmet medical needs, announces that Symbiosis …See details»
Modus Therapeutics Announces the Results of its Global
STOCKHOLM, SWEDEN – 13 May 2019: Modus Therapeutics AB announces the initial results from its Phase II, randomized, double-blind, placebo-controlled study with sevuparin for the …See details»
Modus Therapeutics Holding AB (publ) (MODTX.ST) - Yahoo Finance
Find the latest Modus Therapeutics Holding AB (publ) (MODTX.ST) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
INTERIM REPORT JANUARY – MARCH 2021 - modustx.com
“The Company” or “Modus” refers to the parent company Modus Therapeutics Holding AB with organization number 556951– 9523. “Subsidiary” or “Modus Therapeutics” refers to the …See details»
MODTX Stock Price and Chart — OMXSTO:MODTX - TradingView
Modustx.com. Headquarters. Stockholm. Founded. 2011. ISIN. SE0015987904. FIGI. BBG011KFL2X6. Modus Therapeutics Holding AB operates as a biotechnology company. It …See details»
Press release - Modus Therapeutics
The report is available as an attached document and on the company's website (www.modustx.com). Below is a summary of the interim report. John Öhd, Modus …See details»
MODTX Stock Price Quote | Morningstar
Dec 11, 2024 See the latest Modus Therapeutics Holding AB stock price (MODTX:XSTO), related news, valuation, dividends and more to help you make your investing decisions.See details»
Press release - Modus Therapeutics
More information is available at www.modustx.com. Sevuparin is a clinical stage, innovative proprietary polysaccharide drug with a multimodal mechanism of action, including …See details»